India lacks innovation culture, collaboration is the way forward: Industry

BioSpectrum in association with Scottish Development International (SDI) hosted an iconic premiere panel discussion in June 2015 titled, ‘‘The Road Ahead for the Life Sciences Industry by 2020’.


(Photo Courtesy:

The forum brought India's leading Life Sciences personalities and game changing masterminds to discuss and contemplate the future of Indian Life Sciences industry by the year 2020.

The star-studded panel discussion was garnered by eminent faces including Dr K K Narayanan, MD, Metahelix Life Sciences; Dr Rashmi Barbhaiya, CEO & MD, Advinus Therapeutics; Ms Bindhya Cariappa, COO & EVP Emerging Markets, ClinTec International; Dr Goutam Das, COO, Association of Biotechnology Led Enterprises (ABLE); Ms Rooma Bussi, Country Head - India, SDI; and Dr Sharon McKendry, Life Sciences & Chemical Sciences International Sector Head, SDI.

The panel discussion was moderated by N Suresh, group editor of BioSpectrum publication.

Dr Rashmi began the panel discussion by speaking about the significance of innovation and collaboration in the pharma industry.

"Having spent 30 years in the US, I came back for one reason -- the young Indian talents, since there is no past legacy for them. The manner in which young people go about finding innovation is amazing. Many companies from Europe, US and Japan have been in India for a long time. The cost of innovation in their respective countries is high and hence, they lookout for cheaper labor to solve issues," he opined.


Previous 1 3 4 5 6 Next
1 Comment Comment 1 - 1 of 1

Deepak Chandrasekaran 30 July 2015 at 01:48 PM

An article with highly decorated words, First goal is to restrict the political interference in the companies policies.


Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box


GST: Boon or Bane for Healthcare?

Send this article by email